Starting Dose of Fluoxetine for Panic Disorder
Start fluoxetine at 10 mg/day for panic disorder, then increase to 20 mg/day after one week. 1
FDA-Approved Dosing Strategy
The FDA label provides explicit guidance for panic disorder treatment:
- Initial dose: 10 mg/day 1
- After 1 week: Increase to 20 mg/day 1
- Most frequently used dose in clinical trials: 20 mg/day 1
- Dose range studied: 10-60 mg/day 1
This lower starting dose (10 mg rather than the 20 mg used for depression) is critical because panic disorder patients are particularly sensitive to initial SSRI-induced anxiety and agitation. 2
Rationale for Low-Dose Initiation
Starting at 10 mg minimizes early adverse effects that commonly cause treatment discontinuation in panic disorder patients. The American Academy of Child and Adolescent Psychiatry guidelines emphasize that because an initial adverse effect of SSRIs can be anxiety or agitation, it may be advisable to start with a subtherapeutic dose as a "test" dose. 2
Research supports this conservative approach:
- In one study, 28% of patients could not tolerate the full 20 mg dose, with half discontinuing entirely and half benefiting from lower doses 3
- Patients with panic disorder were particularly likely to discontinue due to intolerance 3
- Starting at 5 mg and gradually increasing to 20 mg over one week improved tolerability 3, 4
Dose Titration Schedule
After the initial week at 10 mg/day:
- Week 2 onward: 20 mg/day (the target therapeutic dose) 1, 5
- If inadequate response after several weeks: Consider increasing dose 1
- Maximum studied dose: 60 mg/day 1
- Titration intervals: 3-4 weeks between increases (due to fluoxetine's long half-life) 2
The 20 mg/day dose has been shown to be safe and efficacious in reducing panic symptoms, with patients who fail to respond potentially benefiting from further increases. 5, 6
Special Considerations
For patients with hepatic impairment, elderly patients, or those on multiple medications: Use lower or less frequent dosing. 1
Fluoxetine's long half-life (1-3 days for parent compound, 7-15 days for active metabolite) allows for:
- Once-daily dosing 1
- Slower titration intervals (3-4 weeks) compared to shorter half-life SSRIs like sertraline (1-2 weeks) 2
- Reduced risk of discontinuation syndrome 1
Common Pitfalls to Avoid
- Do not start at 20 mg in panic disorder patients - this increases risk of early discontinuation due to anxiety/agitation 3, 4
- Do not rush dose escalation - fluoxetine requires 3-4 weeks between increases due to its long half-life 2
- Do not assume higher doses are always better - it is not clear that dose is related to magnitude of response, and higher doses can increase adverse effects 2
- Monitor closely for suicidal ideation - especially in the first months and after dose adjustments (FDA boxed warning for patients through age 24) 2
Expected Timeline
- Initial improvement: May be seen within 2 weeks (statistically but not always clinically significant) 2
- Clinically significant improvement: By week 6 2
- Maximal improvement: Week 12 or later 2
This pharmacodynamic profile supports the slow up-titration strategy to avoid exceeding the optimal dose before therapeutic effects fully manifest. 2